BMY
56
-4
XOM
42
-3
UHS
52
-8
KSS
42
-4
PNW
63
-4
STI
24
3
APH
43
-3
SPG
53
-2
PAYX
51
-3
PX
48
-2
ECL
55
-2
MOS
15
-3
ZION
46
-4
WAT
47
-2
MSI
69
-4
MCHP
32
-6
SRE
50
-7
GS
50
-15
LRCX
42
-4
IVZ
35
-8
BMY
56
-4
XOM
42
-3
UHS
52
-8
KSS
42
-4
PNW
63
-4
STI
24
3
APH
43
-3
SPG
53
-2
PAYX
51
-3
PX
48
-2
ECL
55
-2
MOS
15
-3
ZION
46
-4
WAT
47
-2
MSI
69
-4
MCHP
32
-6
SRE
50
-7
GS
50
-15
LRCX
42
-4
IVZ
35
-8
Financhill
Back

Verve Therapeutics Vs. Caribou Biosciences Industry Stock Comparison

Sell
36

VERV
Verve Therapeutics

Last Price:
5.60
Seasonality Move:
-34.1%
Sell
25

CRBU
Caribou Biosciences

Last Price:
1.73
Seasonality Move:
-16.23%
Sell
36
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics a Buy, Sell or Hold?

  • The current Verve Therapeutics [VERV] share price is $5.60. The Score for VERV is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Caribou Biosciences (CRBU) is a Sell

Is Caribou Biosciences a Buy, Sell or Hold?

  • The current Caribou Biosciences [CRBU] share price is $1.73. The Score for CRBU is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • CRBU is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VERV Stock Price Chart

What is Verve Therapeutics's stock price today?

  • The Verve Therapeutics share price today is $5.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRBU Stock Price Chart

What is Caribou Biosciences's stock price today?

  • The Caribou Biosciences share price today is $1.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBU is experiencing slight selling pressure.

VERV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.86 Sell
Chaikin Money Flow: 756028 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.75 - 6.03) Buy
Bollinger Bands (100): (5.07 - 6.69) Sell

CRBU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 35.08 Sell
Chaikin Money Flow: -445243 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.89 - 2.17) Sell
Bollinger Bands (100): (1.73 - 3.29) Sell

VERV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.94 Sell
20-day SMA: 5.26 Buy
50-day SMA: 5.93 Sell
200-day SMA: 9.27 Sell
8-day EMA: 5.76 Sell
20-day EMA: 5.65 Sell
50-day EMA: 5.86 Sell
200-day EMA: 8.84 Sell

CRBU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.99 Sell
20-day SMA: 2.04 Sell
50-day SMA: 2.05 Sell
200-day SMA: 4.2 Sell
8-day EMA: 1.94 Sell
20-day EMA: 2.03 Sell
50-day EMA: 2.18 Sell
200-day EMA: 3.62 Sell

Verve Therapeutics Earnings Growth & VERV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.

Caribou Biosciences Earnings Growth & CRBU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.12 per share.

Verve Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Caribou Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):